Clinical pharmacology of alendronate sodium
β Scribed by B. J. Gertz; S. D. Holland; W. F. Kline; B. K. Matuszewski; A. G. Porras
- Publisher
- Springer-Verlag
- Year
- 1993
- Tongue
- English
- Weight
- 540 KB
- Volume
- 3
- Category
- Article
- ISSN
- 0937-941X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Methotrexate (MTX), a potent folate antagonist by virtue of its ability to inhibit the enzyme dihydrofolate reductase [1], continues to be a useful cancer chemotherapeutic agent [2]. Information not only on its mechanism of action, but also its pharmacology has led to improved dosage sc
Animal work has shown that carvedilol is a nonselective beta-blocking drug. It has a vasodilator action from alpha-receptor blockade, but there is evidence that it has further action to relax smooth muscle, possibly from calcium channel antagonism. Carvedilol is lipid soluble and 25% bioavailable, a